CardioDx Raises $60M in Private Financing

The cardiovascular genomics testing firm will use the funding to expand reimbursement coverage in the US for its gene expression Corad CAD test.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories